NovusDNA creatine and collagen offer predictable serving sizes, with pouches lasting 60 and 30 days respectively. Calculate usage and plan your next reorder.
What Is Inflammageing? A Simple Guide to Low-Grade Inflammation
Inflammageing is the term researchers use for the chronic, low-grade inflammation that tends to rise with age, even without any infection or illness present. It is measured through markers like interleukin-6 (IL-6), TNF-alpha and C-reactive protein (CRP), and it is linked to a wide range of age-related conditions, from cardiovascular disease to cognitive decline. The honest evidence on what actually reduces it is narrower than supplement marketing suggests: resistance training, omega-3 fatty acids and probiotics have reasonable support, while some popular longevity compounds, including resveratrol and vitamin D, have not shown a clear effect on the key inflammatory markers in clinical trials so far.
Inflammageing sounds technical, but the concept is simple once you separate it from acute inflammation, the kind you get from a cut or an infection. When exploring what is inflammageing, it helps to understand that it operates as a slow, smouldering fire rather than a sudden blaze.
The term was first coined in 2000 by the researcher Claudio Franceschi and colleagues to describe a different, quieter phenomenon: a low, persistent level of inflammatory activity that builds gradually with age, even in people who feel perfectly well. It has become a genuinely important concept in ageing research because of how many different age-related conditions it has been linked to, but that popularity has also meant it gets used loosely, often to justify anti-inflammatory product claims that outpace the actual evidence.
What is Low-Grade Inflammation Ageing?
To truly grasp the mechanisms behind low-grade inflammation ageing, one must look closely at how the body changes over decades. Unlike acute inflammation, which serves as an immediate, life-saving defence mechanism against pathogens, chronic low-grade inflammation lacks a distinct trigger. Instead, it becomes a systemic background state that gradually wears down tissues and accelerates the biological ageing timeline.
As people grow older, the immune system undergoes a remodelling process known as immunosenescence. This shift means that while the body becomes less effective at fighting off new infections, it simultaneously produces a higher baseline output of inflammatory cytokines. This creates a paradox where the system is both suppressed in key areas and chronically overactive in others, fuelling the wider ageing process.
What is Actually Driving Inflammageing
A 2025 review on immunosenescence and inflammaging describes chronic low-grade inflammation as arising from several interconnected sources: persistent activation of innate immune pathways, the senescence-associated secretory phenotype (SASP) released by ageing senescent cells, metabolic dysregulation, and age-related changes in the gut microbiome. Rather than one single cause, inflammageing appears to be the accumulated output of several ageing processes converging on the same inflammatory signalling pathways, which is part of why it connects to so many other topics in ageing research, including cellular senescence and mitochondrial biology.
At the cellular level, the accumulation of damaged macromolecules and dysfunctional mitochondria triggers ongoing oxidative stress. This oxidative damage acts as an internal alarm signal, constantly stimulating immune receptors and perpetuating the cycle of cellular senescence. Over time, these senescent cells refuse to divide or die off quietly; instead, they secrete a toxic cocktail of inflammatory proteins that damage neighbouring healthy tissue and recruit more immune cells to the area.
Why This Is Not Just an Academic Curiosity
The clinical relevance here is genuinely well established, not speculative.
A large study of Eastern European adults aged 65 and older, the PolSenior study, found that elevated IL-6 and CRP levels were meaningful predictors of physical and cognitive performance, and of mortality risk, both across the general elderly population and specifically within people who were otherwise ageing well. This is why inflammageing gets taken seriously in longevity research: it is not just a biomarker curiosity, it is linked to measurable, real-world outcomes in how people function as they age.
Furthermore, systemic inflammation has a profound impact on skin ageing. Just as internal organs experience the wear and tear of chronic immune activation, dermal structures suffer from collagen degradation driven by matrix metalloproteinases activated by inflammatory cytokines. This manifests outwardly as loss of elasticity, wrinkling, and impaired barrier function, proving that the health of our tissues is deeply intertwined with systemic immune balance.
The Part Most Marketing Skips: What Actually Works
This is where it is worth being genuinely precise, because the evidence for different interventions varies a lot more than most anti-inflammatory product marketing suggests.
A systematic review and meta-analysis specifically examining interventions for chronic low-grade inflammation in middle-aged and older adults found that, compared with placebo, omega-3 fatty acids and probiotics significantly reduced both IL-6 and CRP levels, with effect sizes ranging from small to large depending on the compound. The same meta-analysis, however, found no evidence of effectiveness for resveratrol or vitamin D on these same inflammatory markers in the clinical trials reviewed. Separately, a systematic review and meta-analysis of randomised controlled trials found that resistance training significantly reduced CRP and inflammatory cytokines in elderly adults, making it one of the more consistently supported non-pharmacological interventions available.
Where This Leaves Supplement Formulation, Honestly
Given that meta-analysis finding, it is worth being direct about where certain ranges do and do not fit here.
Advanced longevity formulations often include pterostilbene, a resveratrol analogue with preclinical evidence for inhibiting the inflammatory NF-kappaB pathway. But the closest human clinical data available on this class of compound, the resveratrol trials included in the meta-analysis above, did not show a significant effect on IL-6 or CRP specifically. Responsible brands do not market these products as inflammageing treatments for this reason, as the human evidence for that specific outcome is not there yet, even though the preclinical mechanism is genuinely studied. Similarly, vitamin D3, included for its established role in bone and immune health, has not shown a clear effect on IL-6 or CRP in the trials reviewed either, so it is not positioned as an anti-inflammatory solution. Being upfront about that distinction matters more than stretching every ingredient to cover every trending topic.
What Genuinely Helps, Based on the Evidence
Pulled together, the current evidence points to a fairly specific, actionable list: resistance training has solid randomised trial support for reducing inflammatory markers in older adults, and omega-3 fatty acids and probiotics have meaningful support from a dedicated meta-analysis on this exact outcome. None of these are dramatic or exotic interventions, which is arguably the point, as the things that actually move inflammageing markers in trials are largely the same foundations that show up across most areas of healthy ageing research, rather than a specific miracle compound. Brands like Wild Nutrition, BioCare, and Bare Biology often emphasise dietary foundations and whole-food approaches alongside targeted supplementation to support overall systemic balance.
FAQ
What is the difference between inflammageing and normal inflammation from an injury?
Normal, acute inflammation is a short-term, protective response to injury or infection that resolves once the threat is gone. Inflammageing is different: it is a chronic, low-level inflammatory state that persists in the absence of any infection or acute injury, measured through markers like IL-6, TNF-alpha and CRP, and it tends to rise gradually with age. It does not feel like anything specific day to day, which is part of why it is typically identified through blood markers rather than symptoms.
Does inflammageing actually matter for how you function as you age, or is it just a lab marker?
It genuinely matters. A large study of adults aged 65 and older found that elevated IL-6 and CRP levels predicted physical performance, cognitive performance and mortality risk, even among people who were otherwise ageing successfully. This is one of the more clinically validated connections in ageing research, rather than a marker that only shows up in animal studies or small pilot trials.
Do anti-inflammatory supplements like resveratrol actually reduce inflammageing?
Based on the clinical trial evidence reviewed in a dedicated meta-analysis, no, not for the specific markers researchers use to measure inflammageing. That same review found omega-3 fatty acids and probiotics did significantly reduce IL-6 and CRP, while resveratrol and vitamin D did not show a clear effect on these markers in the trials examined. This is a good example of why it matters to check what a compound has actually been shown to do, rather than assuming a general anti-inflammatory reputation applies to every specific outcome.
What is the single most evidence-backed way to reduce inflammageing markers?
Among the options studied specifically for this outcome, resistance training has some of the more consistent randomised trial support, with a systematic review and meta-analysis finding it significantly reduced CRP and inflammatory cytokines in elderly adults. Omega-3 fatty acids and probiotics also have reasonable evidence behind them. None of these require exotic interventions, which is part of why researchers keep returning to the same foundational recommendations across different areas of ageing research.
Inflammageing is a genuinely important, well-evidenced concept, capturing chronic low-grade inflammation that rises with age and predicts real outcomes like physical function and mortality risk. What the honest evidence shows about managing it is narrower than most supplement marketing implies: resistance training, omega-3s and probiotics have real trial support, while some popular longevity compounds, including resveratrol and vitamin D, have not shown the same effect on the specific markers that define inflammageing. Transparent wellness formulations prefer to be clear about which pathway each product actually addresses rather than stretching claims beyond existing trial data.